Allergan To Pay $2.7M To End Certain Generic-Delay Claims

By Hailey Konnath · August 2, 2019, 10:03 PM EDT

Allergan will pay a combined $2.7 million and allow judgment to be entered against it to resolve claims from three of the plaintiffs accusing the company's subsidiary of delaying generic competition...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login